Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.37840579 |
2 | embryonic process involved in female pregnancy (GO:0060136) | 4.78458726 |
3 | regulation of integrin activation (GO:0033623) | 4.51885162 |
4 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.46622127 |
5 | B cell receptor signaling pathway (GO:0050853) | 4.42222942 |
6 | interferon-gamma secretion (GO:0072643) | 4.33997409 |
7 | cellular response to exogenous dsRNA (GO:0071360) | 4.31603684 |
8 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 4.30477909 |
9 | megakaryocyte development (GO:0035855) | 4.19267454 |
10 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.16383742 |
11 | proline biosynthetic process (GO:0006561) | 4.01164131 |
12 | B cell mediated immunity (GO:0019724) | 3.91878120 |
13 | rRNA catabolic process (GO:0016075) | 3.88598438 |
14 | regulation of germinal center formation (GO:0002634) | 3.80159944 |
15 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.61594650 |
16 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.61588968 |
17 | positive regulation of organelle assembly (GO:1902117) | 3.59211155 |
18 | definitive hemopoiesis (GO:0060216) | 3.51760854 |
19 | regulation of platelet activation (GO:0010543) | 3.50780396 |
20 | positive regulation of protein homooligomerization (GO:0032464) | 3.50471499 |
21 | response to UV-C (GO:0010225) | 3.48429609 |
22 | positive regulation of antigen processing and presentation (GO:0002579) | 3.48379308 |
23 | negative regulation of B cell apoptotic process (GO:0002903) | 3.46136063 |
24 | regulation of antigen processing and presentation (GO:0002577) | 3.42898557 |
25 | regulation of B cell apoptotic process (GO:0002902) | 3.42521309 |
26 | negative thymic T cell selection (GO:0045060) | 3.38390841 |
27 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.37608241 |
28 | positive T cell selection (GO:0043368) | 3.37188174 |
29 | response to interferon-beta (GO:0035456) | 3.34560097 |
30 | establishment of apical/basal cell polarity (GO:0035089) | 3.31284536 |
31 | embryonic placenta development (GO:0001892) | 3.30975817 |
32 | apoptotic process involved in morphogenesis (GO:0060561) | 3.30545351 |
33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30527489 |
34 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.27609531 |
35 | replication fork processing (GO:0031297) | 3.25449444 |
36 | regulation of regulatory T cell differentiation (GO:0045589) | 3.25421551 |
37 | positive regulation of interferon-alpha production (GO:0032727) | 3.25338297 |
38 | cellular response to interferon-beta (GO:0035458) | 3.24583952 |
39 | growth hormone receptor signaling pathway (GO:0060396) | 3.24220627 |
40 | neutrophil activation involved in immune response (GO:0002283) | 3.21998004 |
41 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.20759442 |
42 | trophectodermal cell differentiation (GO:0001829) | 3.17472655 |
43 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.17459674 |
44 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.17273246 |
45 | cellular response to zinc ion (GO:0071294) | 3.16053413 |
46 | positive regulation of granulocyte differentiation (GO:0030854) | 3.14106597 |
47 | positive regulation by host of viral transcription (GO:0043923) | 3.12432020 |
48 | UV protection (GO:0009650) | 3.10816718 |
49 | cellular response to dsRNA (GO:0071359) | 3.09477767 |
50 | dosage compensation (GO:0007549) | 3.08440961 |
51 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.07533464 |
52 | transcription from mitochondrial promoter (GO:0006390) | 3.07147856 |
53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05948777 |
54 | positive regulation by symbiont of host defense response (GO:0052509) | 3.03518495 |
55 | modulation by symbiont of host defense response (GO:0052031) | 3.03518495 |
56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.03518495 |
57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.03518495 |
58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.03518495 |
59 | modulation by symbiont of host immune response (GO:0052553) | 3.03518495 |
60 | negative T cell selection (GO:0043383) | 3.03434218 |
61 | regulation of interferon-alpha production (GO:0032647) | 3.02694709 |
62 | negative regulation of cell killing (GO:0031342) | 3.01923687 |
63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01923687 |
64 | thrombin receptor signaling pathway (GO:0070493) | 3.00373979 |
65 | negative regulation of granulocyte differentiation (GO:0030853) | 2.97934094 |
66 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.95697485 |
67 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.93925718 |
68 | cellular response to growth hormone stimulus (GO:0071378) | 2.93684677 |
69 | thymic T cell selection (GO:0045061) | 2.93461785 |
70 | mast cell activation (GO:0045576) | 2.92512624 |
71 | regulation of translational fidelity (GO:0006450) | 2.92273674 |
72 | positive regulation of defense response to virus by host (GO:0002230) | 2.90765243 |
73 | positive regulation of glomerulus development (GO:0090193) | 2.90149382 |
74 | regulation of mesoderm development (GO:2000380) | 2.89404587 |
75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88119785 |
76 | regulation of sister chromatid cohesion (GO:0007063) | 2.83982891 |
77 | pinocytosis (GO:0006907) | 2.83116028 |
78 | mitotic G1/S transition checkpoint (GO:0044819) | 2.80033157 |
79 | regulation of female receptivity (GO:0045924) | 2.78908628 |
80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.76304245 |
81 | positive regulation of interferon-beta production (GO:0032728) | 2.76296408 |
82 | positive regulation of protein oligomerization (GO:0032461) | 2.76179820 |
83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75945588 |
84 | regulation of RNA export from nucleus (GO:0046831) | 2.74944500 |
85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74916963 |
86 | T cell selection (GO:0045058) | 2.74163923 |
87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73978432 |
88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73978432 |
89 | response to host immune response (GO:0052572) | 2.73791680 |
90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.73791680 |
91 | response to laminar fluid shear stress (GO:0034616) | 2.73600343 |
92 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.73386834 |
93 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.73386834 |
94 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.73386834 |
95 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.72334011 |
96 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.72275400 |
97 | response to peptidoglycan (GO:0032494) | 2.72164153 |
98 | regulation of interferon-beta production (GO:0032648) | 2.69235835 |
99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69203096 |
100 | heterochromatin organization (GO:0070828) | 2.68993345 |
101 | negative regulation of interleukin-12 production (GO:0032695) | 2.68451062 |
102 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.65970277 |
103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.64186045 |
104 | RNA destabilization (GO:0050779) | 2.64137667 |
105 | G1 DNA damage checkpoint (GO:0044783) | 2.63962216 |
106 | protein localization to endosome (GO:0036010) | 2.63887134 |
107 | detection of bacterium (GO:0016045) | 2.63084939 |
108 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.62434059 |
109 | anatomical structure regression (GO:0060033) | 2.61935215 |
110 | mature B cell differentiation involved in immune response (GO:0002313) | 2.61831963 |
111 | angiogenesis involved in wound healing (GO:0060055) | 2.61454531 |
112 | myeloid cell activation involved in immune response (GO:0002275) | 2.59878054 |
113 | T-helper 1 type immune response (GO:0042088) | 2.59582295 |
114 | lymphocyte homeostasis (GO:0002260) | 2.59268436 |
115 | B cell homeostasis (GO:0001782) | 2.59008014 |
116 | positive regulation of interleukin-17 production (GO:0032740) | 2.57633618 |
117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.56260349 |
118 | response to host (GO:0075136) | 2.56260349 |
119 | response to host defenses (GO:0052200) | 2.56260349 |
120 | regulation of protein homooligomerization (GO:0032462) | 2.54858148 |
121 | histone H4-K12 acetylation (GO:0043983) | 2.54485940 |
122 | negative regulation of bone mineralization (GO:0030502) | 2.54463409 |
123 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53225588 |
124 | establishment of monopolar cell polarity (GO:0061162) | 2.52347392 |
125 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.52347392 |
126 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.51875416 |
127 | proline metabolic process (GO:0006560) | 2.51657644 |
128 | negative regulation of cell cycle arrest (GO:0071157) | 2.51608635 |
129 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51254719 |
130 | mitochondrial DNA metabolic process (GO:0032042) | 2.50897947 |
131 | formation of translation preinitiation complex (GO:0001731) | 2.48705400 |
132 | face development (GO:0060324) | 2.47779250 |
133 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.44869786 |
134 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.44869786 |
135 | positive regulation of histone deacetylation (GO:0031065) | 2.44692415 |
136 | negative regulation of RNA splicing (GO:0033119) | 2.44147919 |
137 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.43903983 |
138 | meiotic chromosome segregation (GO:0045132) | 2.43352104 |
139 | regulation of gamma-delta T cell activation (GO:0046643) | 2.42845287 |
140 | positive regulation of chromosome segregation (GO:0051984) | 2.41921813 |
141 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.41359184 |
142 | embryonic camera-type eye development (GO:0031076) | 2.39838026 |
143 | DNA topological change (GO:0006265) | 2.37398336 |
144 | mRNA cleavage (GO:0006379) | 2.37046284 |
145 | negative regulation of mRNA processing (GO:0050686) | 2.36738551 |
146 | pre-miRNA processing (GO:0031054) | 2.33629810 |
147 | positive thymic T cell selection (GO:0045059) | 2.32141946 |
148 | embryonic eye morphogenesis (GO:0048048) | 2.31977607 |
149 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.30724069 |
150 | mitotic sister chromatid segregation (GO:0000070) | 2.29790243 |
151 | regulation of podosome assembly (GO:0071801) | 2.29512775 |
152 | developmental programmed cell death (GO:0010623) | 2.29045994 |
153 | mRNA stabilization (GO:0048255) | 2.27788708 |
154 | RNA stabilization (GO:0043489) | 2.27788708 |
155 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27226219 |
156 | mitotic nuclear envelope disassembly (GO:0007077) | 2.26363440 |
157 | negative regulation of viral release from host cell (GO:1902187) | 2.25158382 |
158 | apoptotic process involved in development (GO:1902742) | 2.24417704 |
159 | positive regulation of B cell differentiation (GO:0045579) | 2.23783325 |
160 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.23753920 |
161 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.23645150 |
162 | regulation of gene silencing by miRNA (GO:0060964) | 2.23645150 |
163 | regulation of gene silencing by RNA (GO:0060966) | 2.23645150 |
164 | base-excision repair (GO:0006284) | 2.21627351 |
165 | determination of adult lifespan (GO:0008340) | 2.21352709 |
166 | protein localization to kinetochore (GO:0034501) | 2.20941121 |
167 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.20619612 |
168 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.20366838 |
169 | negative regulation of interleukin-8 production (GO:0032717) | 2.20227143 |
170 | regulation of hippo signaling (GO:0035330) | 2.19324855 |
171 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.19308851 |
172 | DNA deamination (GO:0045006) | 2.19195805 |
173 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.18860624 |
174 | hepatocyte apoptotic process (GO:0097284) | 2.18187004 |
175 | sister chromatid segregation (GO:0000819) | 2.17945382 |
176 | DNA strand renaturation (GO:0000733) | 2.17013424 |
177 | retinoic acid receptor signaling pathway (GO:0048384) | 2.15475905 |
178 | hypotonic response (GO:0006971) | 2.14062427 |
179 | V(D)J recombination (GO:0033151) | 2.13301449 |
180 | regulation of B cell differentiation (GO:0045577) | 2.13204236 |
181 | negative regulation of glial cell proliferation (GO:0060253) | 2.12974522 |
182 | immunoglobulin mediated immune response (GO:0016064) | 2.12491795 |
183 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.12461271 |
184 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.11883876 |
185 | negative regulation of mRNA metabolic process (GO:1903312) | 2.10739900 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.54281374 |
2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.13382084 |
3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.76242695 |
4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.25469240 |
5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.18381106 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 3.11831686 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.01251054 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.99860935 |
9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.95915210 |
10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93300389 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.58238507 |
12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.12032652 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09639015 |
14 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.03563112 |
15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02675210 |
16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02565516 |
17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.94480921 |
18 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.93423575 |
19 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.93423575 |
20 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.93423575 |
21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.92779053 |
22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.89495317 |
23 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.86986704 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.86482433 |
25 | * MAF_26560356_Chip-Seq_TH1_Human | 1.83116072 |
26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82040438 |
27 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.81896114 |
28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81433389 |
29 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81254419 |
30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80298622 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77040503 |
32 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76970838 |
33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76490137 |
34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.75575237 |
35 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75501258 |
36 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.72488724 |
37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71040363 |
38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.71040293 |
39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70192683 |
40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.66045826 |
41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.64868621 |
42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.63685516 |
43 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63107232 |
44 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.62762212 |
45 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62443658 |
46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58436188 |
47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56810529 |
48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56692720 |
49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54765519 |
50 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54663922 |
51 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54432477 |
52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.54382816 |
53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54027122 |
54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53300845 |
55 | GATA2_19941826_ChIP-Seq_K562_Human | 1.50044029 |
56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49702299 |
57 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.45473535 |
58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44372757 |
59 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43318921 |
60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42607206 |
61 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42158517 |
62 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.41543253 |
63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41388330 |
64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41256632 |
65 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40903684 |
66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40817105 |
67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40803579 |
68 | * MYB_26560356_Chip-Seq_TH1_Human | 1.39674880 |
69 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.39215884 |
70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39002279 |
71 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.38287567 |
72 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37047354 |
73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36985157 |
74 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35558425 |
75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35504697 |
76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35180936 |
77 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.34833589 |
78 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33688069 |
79 | * MYB_26560356_Chip-Seq_TH2_Human | 1.32792932 |
80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29959297 |
81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.29220795 |
82 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27046579 |
83 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26771711 |
84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26345720 |
85 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.25473220 |
86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.25345388 |
87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24608428 |
88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24327020 |
89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23454041 |
90 | MAF_26560356_Chip-Seq_TH2_Human | 1.22339113 |
91 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.21930824 |
92 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21474755 |
93 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20647632 |
94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20260508 |
95 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.20094958 |
96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17510094 |
97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16991283 |
98 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16590092 |
99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14264719 |
100 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.14003946 |
101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13767729 |
102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13404836 |
103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13303350 |
104 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11483273 |
105 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11060686 |
106 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10626321 |
107 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10435302 |
108 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10292467 |
109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10141217 |
110 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09518641 |
111 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09483272 |
112 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08894677 |
113 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08013384 |
114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06218592 |
115 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.04740118 |
116 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04326072 |
117 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.03580045 |
118 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.03431738 |
119 | * P300_27268052_Chip-Seq_Bcells_Human | 1.03198462 |
120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02959451 |
121 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02702862 |
122 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02241941 |
123 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00887016 |
124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00377598 |
125 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00014470 |
126 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.99584579 |
127 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98140084 |
128 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98055329 |
129 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98027242 |
130 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97995728 |
131 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97473481 |
132 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97314497 |
133 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96474447 |
134 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95483102 |
135 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.94882457 |
136 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93696350 |
137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93687414 |
138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93497591 |
139 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92653980 |
140 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92263084 |
141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92131285 |
142 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92031962 |
143 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.91559695 |
144 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91120478 |
145 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90903074 |
146 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90539941 |
147 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90179345 |
148 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89817927 |
149 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89689651 |
150 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89391854 |
151 | P68_20966046_ChIP-Seq_HELA_Human | 0.88490673 |
152 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87531917 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 3.61717548 |
2 | MP0002138_abnormal_hepatobiliary_system | 3.49353668 |
3 | MP0009278_abnormal_bone_marrow | 3.43839092 |
4 | MP0008057_abnormal_DNA_replication | 2.65177689 |
5 | MP0005646_abnormal_pituitary_gland | 2.65112085 |
6 | MP0010352_gastrointestinal_tract_polyps | 2.55474709 |
7 | MP0002148_abnormal_hypersensitivity_rea | 2.54815536 |
8 | MP0005076_abnormal_cell_differentiation | 2.28688974 |
9 | MP0004885_abnormal_endolymph | 2.19214888 |
10 | MP0001545_abnormal_hematopoietic_system | 2.12332234 |
11 | MP0005397_hematopoietic_system_phenotyp | 2.12332234 |
12 | MP0003705_abnormal_hypodermis_morpholog | 2.10863851 |
13 | MP0000685_abnormal_immune_system | 2.02311562 |
14 | MP0002396_abnormal_hematopoietic_system | 2.01191068 |
15 | MP0004782_abnormal_surfactant_physiolog | 2.00882572 |
16 | MP0001533_abnormal_skeleton_physiology | 1.97276932 |
17 | MP0003566_abnormal_cell_adhesion | 1.93747310 |
18 | MP0005670_abnormal_white_adipose | 1.80802334 |
19 | MP0009780_abnormal_chondrocyte_physiolo | 1.80177642 |
20 | MP0000467_abnormal_esophagus_morphology | 1.79321271 |
21 | MP0002166_altered_tumor_susceptibility | 1.75464717 |
22 | MP0003300_gastrointestinal_ulcer | 1.70335165 |
23 | MP0001851_eye_inflammation | 1.66263350 |
24 | MP0003303_peritoneal_inflammation | 1.64294442 |
25 | MP0000490_abnormal_crypts_of | 1.59363299 |
26 | MP0009053_abnormal_anal_canal | 1.59234391 |
27 | MP0003453_abnormal_keratinocyte_physiol | 1.58969681 |
28 | MP0002009_preneoplasia | 1.58795513 |
29 | MP0004808_abnormal_hematopoietic_stem | 1.56525779 |
30 | MP0002405_respiratory_system_inflammati | 1.55444112 |
31 | MP0003828_pulmonary_edema | 1.54947896 |
32 | MP0010094_abnormal_chromosome_stability | 1.53474772 |
33 | MP0004130_abnormal_muscle_cell | 1.53338691 |
34 | MP0002876_abnormal_thyroid_physiology | 1.51313369 |
35 | MP0005023_abnormal_wound_healing | 1.51291647 |
36 | MP0003283_abnormal_digestive_organ | 1.46068769 |
37 | MP0003763_abnormal_thymus_physiology | 1.45161640 |
38 | MP0001835_abnormal_antigen_presentation | 1.44985732 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.43220195 |
40 | MP0001800_abnormal_humoral_immune | 1.43177280 |
41 | MP0000383_abnormal_hair_follicle | 1.43006301 |
42 | MP0010307_abnormal_tumor_latency | 1.40939544 |
43 | MP0003436_decreased_susceptibility_to | 1.39617531 |
44 | MP0006082_CNS_inflammation | 1.39368589 |
45 | MP0002398_abnormal_bone_marrow | 1.38058874 |
46 | MP0003111_abnormal_nucleus_morphology | 1.36422164 |
47 | MP0003077_abnormal_cell_cycle | 1.36413531 |
48 | MP0010030_abnormal_orbit_morphology | 1.35849042 |
49 | MP0004957_abnormal_blastocyst_morpholog | 1.34666418 |
50 | MP0002006_tumorigenesis | 1.34428554 |
51 | MP0001790_abnormal_immune_system | 1.30572244 |
52 | MP0005387_immune_system_phenotype | 1.30572244 |
53 | MP0010155_abnormal_intestine_physiology | 1.30446329 |
54 | MP0000689_abnormal_spleen_morphology | 1.30404550 |
55 | * MP0002086_abnormal_extraembryonic_tissu | 1.29982846 |
56 | MP0002452_abnormal_antigen_presenting | 1.29513919 |
57 | MP0005058_abnormal_lysosome_morphology | 1.23351898 |
58 | MP0002722_abnormal_immune_system | 1.22867939 |
59 | MP0009785_altered_susceptibility_to | 1.22589965 |
60 | MP0003693_abnormal_embryo_hatching | 1.22530217 |
61 | MP0008438_abnormal_cutaneous_collagen | 1.22310639 |
62 | MP0000350_abnormal_cell_proliferation | 1.18898539 |
63 | MP0003045_fibrosis | 1.18001896 |
64 | MP0000703_abnormal_thymus_morphology | 1.17471897 |
65 | MP0009764_decreased_sensitivity_to | 1.17283000 |
66 | MP0003191_abnormal_cellular_cholesterol | 1.16558822 |
67 | MP0003279_aneurysm | 1.16193707 |
68 | MP0002060_abnormal_skin_morphology | 1.14863934 |
69 | MP0001663_abnormal_digestive_system | 1.14467786 |
70 | MP0002420_abnormal_adaptive_immunity | 1.14015869 |
71 | MP0004185_abnormal_adipocyte_glucose | 1.13742712 |
72 | MP0005390_skeleton_phenotype | 1.13724955 |
73 | MP0001819_abnormal_immune_cell | 1.13395905 |
74 | MP0004197_abnormal_fetal_growth/weight/ | 1.13155795 |
75 | MP0000716_abnormal_immune_system | 1.13120592 |
76 | MP0003448_altered_tumor_morphology | 1.12496680 |
77 | MP0002019_abnormal_tumor_incidence | 1.11982111 |
78 | MP0005464_abnormal_platelet_physiology | 1.11840776 |
79 | MP0008004_abnormal_stomach_pH | 1.10890379 |
80 | MP0004947_skin_inflammation | 1.10584676 |
81 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07909014 |
82 | MP0002723_abnormal_immune_serum | 1.07534380 |
83 | MP0001873_stomach_inflammation | 1.07159222 |
84 | * MP0005380_embryogenesis_phenotype | 1.06651421 |
85 | * MP0001672_abnormal_embryogenesis/_devel | 1.06651421 |
86 | MP0005174_abnormal_tail_pigmentation | 1.04247674 |
87 | * MP0003984_embryonic_growth_retardation | 1.04158767 |
88 | MP0002429_abnormal_blood_cell | 1.04093598 |
89 | MP0005000_abnormal_immune_tolerance | 1.03699185 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 1.03619749 |
91 | MP0002877_abnormal_melanocyte_morpholog | 1.03354892 |
92 | * MP0001697_abnormal_embryo_size | 1.02920882 |
93 | MP0009765_abnormal_xenobiotic_induced | 1.02879339 |
94 | MP0005666_abnormal_adipose_tissue | 1.02510823 |
95 | * MP0002088_abnormal_embryonic_growth/wei | 1.02320365 |
96 | MP0000733_abnormal_muscle_development | 1.02310383 |
97 | MP0005671_abnormal_response_to | 1.02297132 |
98 | MP0000613_abnormal_salivary_gland | 1.01328723 |
99 | MP0002998_abnormal_bone_remodeling | 1.01301474 |
100 | MP0005220_abnormal_exocrine_pancreas | 0.99793834 |
101 | MP0002084_abnormal_developmental_patter | 0.99708643 |
102 | MP0001849_ear_inflammation | 0.99564634 |
103 | MP0004264_abnormal_extraembryonic_tissu | 0.99017025 |
104 | MP0005025_abnormal_response_to | 0.98706984 |
105 | MP0009379_abnormal_foot_pigmentation | 0.98486581 |
106 | MP0001661_extended_life_span | 0.96030700 |
107 | MP0001730_embryonic_growth_arrest | 0.95855204 |
108 | MP0000015_abnormal_ear_pigmentation | 0.95732788 |
109 | MP0003091_abnormal_cell_migration | 0.95272401 |
110 | * MP0002085_abnormal_embryonic_tissue | 0.94616901 |
111 | MP0010678_abnormal_skin_adnexa | 0.94521360 |
112 | MP0004233_abnormal_muscle_weight | 0.92660356 |
113 | MP0002419_abnormal_innate_immunity | 0.91670457 |
114 | MP0000681_abnormal_thyroid_gland | 0.91605689 |
115 | MP0000537_abnormal_urethra_morphology | 0.90860107 |
116 | MP0000767_abnormal_smooth_muscle | 0.90420386 |
117 | MP0006054_spinal_hemorrhage | 0.89794217 |
118 | MP0000858_altered_metastatic_potential | 0.89596869 |
119 | * MP0002925_abnormal_cardiovascular_devel | 0.89328134 |
120 | MP0005083_abnormal_biliary_tract | 0.89254951 |
121 | MP0008775_abnormal_heart_ventricle | 0.88964814 |
122 | MP0002796_impaired_skin_barrier | 0.88931086 |
123 | MP0008058_abnormal_DNA_repair | 0.88521173 |
124 | MP0000343_altered_response_to | 0.88216764 |
125 | MP0001764_abnormal_homeostasis | 0.86667633 |
126 | MP0000465_gastrointestinal_hemorrhage | 0.86486176 |
127 | MP0008007_abnormal_cellular_replicative | 0.84724262 |
128 | MP0005501_abnormal_skin_physiology | 0.82704090 |
129 | MP0002933_joint_inflammation | 0.82419213 |
130 | MP0008469_abnormal_protein_level | 0.82324401 |
131 | * MP0010630_abnormal_cardiac_muscle | 0.82318396 |
132 | MP0003172_abnormal_lysosome_physiology | 0.82030093 |
133 | MP0000477_abnormal_intestine_morphology | 0.81689898 |
134 | MP0009931_abnormal_skin_appearance | 0.80061909 |
135 | MP0005508_abnormal_skeleton_morphology | 0.79932589 |
136 | MP0000371_diluted_coat_color | 0.79133688 |
137 | * MP0002080_prenatal_lethality | 0.79132827 |
138 | MP0001845_abnormal_inflammatory_respons | 0.78667606 |
139 | MP0009643_abnormal_urine_homeostasis | 0.78543084 |
140 | MP0004883_abnormal_blood_vessel | 0.78390697 |
141 | MP0000313_abnormal_cell_death | 0.77990921 |
142 | MP0000230_abnormal_systemic_arterial | 0.76581255 |
143 | MP0002132_abnormal_respiratory_system | 0.76410718 |
144 | MP0001853_heart_inflammation | 0.76180882 |
145 | MP0003806_abnormal_nucleotide_metabolis | 0.76110074 |
146 | MP0005381_digestive/alimentary_phenotyp | 0.74831327 |
147 | MP0002254_reproductive_system_inflammat | 0.74246844 |
148 | MP0003638_abnormal_response/metabolism_ | 0.73849146 |
149 | MP0005164_abnormal_response_to | 0.72936566 |
150 | MP0002282_abnormal_trachea_morphology | 0.72307576 |
151 | MP0003646_muscle_fatigue | 0.71207782 |
152 | MP0003183_abnormal_peptide_metabolism | 0.71045479 |
153 | MP0005409_darkened_coat_color | 0.70603707 |
154 | MP0003786_premature_aging | 0.69403030 |
155 | MP0005310_abnormal_salivary_gland | 0.69216278 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Pustule (HP:0200039) | 4.01083481 |
2 | Cerebral aneurysm (HP:0004944) | 3.78496707 |
3 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.66249888 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56392167 |
5 | Ulnar bowing (HP:0003031) | 3.46306660 |
6 | Abnormality of the columella (HP:0009929) | 3.32595036 |
7 | Abnormality of the prostate (HP:0008775) | 3.31539237 |
8 | Autoimmune hemolytic anemia (HP:0001890) | 3.26697914 |
9 | Abnormality of the nasal septum (HP:0000419) | 3.07794273 |
10 | Rib fusion (HP:0000902) | 2.94623287 |
11 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.87253861 |
12 | Thrombocytosis (HP:0001894) | 2.87155487 |
13 | Morphological abnormality of the middle ear (HP:0008609) | 2.84642220 |
14 | Stomach cancer (HP:0012126) | 2.83179254 |
15 | Agammaglobulinemia (HP:0004432) | 2.82229266 |
16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.77473393 |
17 | Abnormal number of erythroid precursors (HP:0012131) | 2.75128633 |
18 | Prostate neoplasm (HP:0100787) | 2.69007690 |
19 | Hyperthyroidism (HP:0000836) | 2.67799826 |
20 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.66643845 |
21 | Abnormality of B cell number (HP:0010975) | 2.59992755 |
22 | Short 1st metacarpal (HP:0010034) | 2.58900441 |
23 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.58900441 |
24 | Intestinal fistula (HP:0100819) | 2.57934502 |
25 | Meningitis (HP:0001287) | 2.57920094 |
26 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.57161167 |
27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.57161167 |
28 | Abnormality of glycolipid metabolism (HP:0010969) | 2.57161167 |
29 | Mediastinal lymphadenopathy (HP:0100721) | 2.55236261 |
30 | Alopecia of scalp (HP:0002293) | 2.54126596 |
31 | Acute lymphatic leukemia (HP:0006721) | 2.53803633 |
32 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.51516360 |
33 | Obstructive lung disease (HP:0006536) | 2.51500780 |
34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51500780 |
35 | Poikiloderma (HP:0001029) | 2.51471990 |
36 | B lymphocytopenia (HP:0010976) | 2.50043833 |
37 | Stomatitis (HP:0010280) | 2.48632343 |
38 | Abnormality of the fingertips (HP:0001211) | 2.46230361 |
39 | Cellulitis (HP:0100658) | 2.44088263 |
40 | Colitis (HP:0002583) | 2.40166882 |
41 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.37664150 |
42 | Asplenia (HP:0001746) | 2.37141920 |
43 | Recurrent fungal infections (HP:0002841) | 2.36476965 |
44 | Entropion (HP:0000621) | 2.36227207 |
45 | Granulocytopenia (HP:0001913) | 2.35770176 |
46 | Facial hemangioma (HP:0000329) | 2.35306954 |
47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32992681 |
48 | Epistaxis (HP:0000421) | 2.30463210 |
49 | Basal cell carcinoma (HP:0002671) | 2.29256820 |
50 | Abnormality of the 1st metacarpal (HP:0010009) | 2.28587875 |
51 | Thyroid-stimulating hormone excess (HP:0002925) | 2.26131829 |
52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25539663 |
53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25539663 |
54 | Mucopolysacchariduria (HP:0008155) | 2.25510348 |
55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25510348 |
56 | Rectal fistula (HP:0100590) | 2.22216270 |
57 | Rectovaginal fistula (HP:0000143) | 2.22216270 |
58 | Short humerus (HP:0005792) | 2.21752376 |
59 | Abnormality of the costochondral junction (HP:0000919) | 2.21285603 |
60 | Hypoplasia of the odontoid process (HP:0003311) | 2.20517767 |
61 | Spontaneous hematomas (HP:0007420) | 2.20209355 |
62 | Inflammation of the large intestine (HP:0002037) | 2.20207917 |
63 | Eczematoid dermatitis (HP:0000976) | 2.20202653 |
64 | Gastrointestinal inflammation (HP:0004386) | 2.19688959 |
65 | Dysostosis multiplex (HP:0000943) | 2.19101173 |
66 | Polycythemia (HP:0001901) | 2.18825565 |
67 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.18584825 |
68 | Protrusio acetabuli (HP:0003179) | 2.18298835 |
69 | Recurrent viral infections (HP:0004429) | 2.18094015 |
70 | Chest pain (HP:0100749) | 2.16564539 |
71 | IgG deficiency (HP:0004315) | 2.16459678 |
72 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.15438236 |
73 | Vertebral hypoplasia (HP:0008417) | 2.15438236 |
74 | Conjunctival hamartoma (HP:0100780) | 2.14691554 |
75 | Selective tooth agenesis (HP:0001592) | 2.13276126 |
76 | Annular pancreas (HP:0001734) | 2.11171019 |
77 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.10897001 |
78 | IgA deficiency (HP:0002720) | 2.09498562 |
79 | Hypochromic anemia (HP:0001931) | 2.08489597 |
80 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.08176046 |
81 | Bilateral microphthalmos (HP:0007633) | 2.06321996 |
82 | Volvulus (HP:0002580) | 2.05570855 |
83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05165887 |
84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05165887 |
85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05165887 |
86 | Hypochromic microcytic anemia (HP:0004840) | 2.04818488 |
87 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.04535214 |
88 | Short femoral neck (HP:0100864) | 2.04487527 |
89 | Vasculitis (HP:0002633) | 2.04196332 |
90 | Arterial thrombosis (HP:0004420) | 2.03818396 |
91 | Long nose (HP:0003189) | 2.03549114 |
92 | Myocardial infarction (HP:0001658) | 2.03286276 |
93 | Truncus arteriosus (HP:0001660) | 2.03221363 |
94 | Chronic otitis media (HP:0000389) | 2.03003426 |
95 | Short hallux (HP:0010109) | 2.02353034 |
96 | Abnormality of male internal genitalia (HP:0000022) | 2.01683533 |
97 | Hematochezia (HP:0002573) | 2.00048082 |
98 | Vaginal fistula (HP:0004320) | 1.99922654 |
99 | Abnormality of DNA repair (HP:0003254) | 1.99568391 |
100 | Recurrent abscess formation (HP:0002722) | 1.99425383 |
101 | Urethral obstruction (HP:0000796) | 1.99399640 |
102 | Cutaneous melanoma (HP:0012056) | 1.98184295 |
103 | Bowed forearm bones (HP:0003956) | 1.98175907 |
104 | Bowing of the arm (HP:0006488) | 1.98175907 |
105 | Aortic aneurysm (HP:0004942) | 1.97808449 |
106 | Premature skin wrinkling (HP:0100678) | 1.97802974 |
107 | Alveolar cell carcinoma (HP:0006519) | 1.97634734 |
108 | Joint stiffness (HP:0001387) | 1.97580029 |
109 | Abnormality of the odontoid process (HP:0003310) | 1.97154661 |
110 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.96896355 |
111 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.96880446 |
112 | Polygenic inheritance (HP:0010982) | 1.94922357 |
113 | Microvesicular hepatic steatosis (HP:0001414) | 1.94868992 |
114 | Paralysis (HP:0003470) | 1.92566050 |
115 | Amaurosis fugax (HP:0100576) | 1.92139749 |
116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91143999 |
117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90661926 |
118 | Increased IgM level (HP:0003496) | 1.90409394 |
119 | Flared iliac wings (HP:0002869) | 1.87060160 |
120 | Spondylolisthesis (HP:0003302) | 1.87040858 |
121 | Abnormality of the nasal mucosa (HP:0000433) | 1.86801385 |
122 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85982777 |
123 | Abnormality of T cell physiology (HP:0011840) | 1.85795185 |
124 | Pulmonary infiltrates (HP:0002113) | 1.85481165 |
125 | Abnormal hemoglobin (HP:0011902) | 1.85435713 |
126 | IgM deficiency (HP:0002850) | 1.85280793 |
127 | Abnormal platelet volume (HP:0011876) | 1.85234430 |
128 | Absent/shortened dynein arms (HP:0200106) | 1.84139049 |
129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84139049 |
130 | Eosinophilia (HP:0001880) | 1.83483335 |
131 | Orthostatic hypotension (HP:0001278) | 1.81772187 |
132 | Ankle contracture (HP:0006466) | 1.81100571 |
133 | Recurrent skin infections (HP:0001581) | 1.80661959 |
134 | Squamous cell carcinoma (HP:0002860) | 1.80432700 |
135 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.80071235 |
136 | Short phalanx of the thumb (HP:0009660) | 1.79498025 |
137 | Carpal bone hypoplasia (HP:0001498) | 1.78876819 |
138 | Methylmalonic acidemia (HP:0002912) | 1.78614893 |
139 | Microcytic anemia (HP:0001935) | 1.77795938 |
140 | Autoimmune thrombocytopenia (HP:0001973) | 1.77476536 |
141 | Genu recurvatum (HP:0002816) | 1.75418962 |
142 | Muscle fibrillation (HP:0010546) | 1.75370525 |
143 | Mitral valve prolapse (HP:0001634) | 1.74266900 |
144 | Concave nail (HP:0001598) | 1.74146366 |
145 | Abnormality of T cells (HP:0002843) | 1.73961496 |
146 | Long eyelashes (HP:0000527) | 1.73617295 |
147 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.72488780 |
148 | Osteolytic defects of the hand bones (HP:0009699) | 1.72488780 |
149 | Male infertility (HP:0003251) | 1.71834034 |
150 | Cheilitis (HP:0100825) | 1.71215621 |
151 | Albinism (HP:0001022) | 1.70231441 |
152 | Syringomyelia (HP:0003396) | 1.69716089 |
153 | Spinal cord lesions (HP:0100561) | 1.69716089 |
154 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.69194736 |
155 | Short 4th metacarpal (HP:0010044) | 1.69194736 |
156 | Nasal polyposis (HP:0100582) | 1.68175611 |
157 | Aneurysm (HP:0002617) | 1.68159596 |
158 | Shallow orbits (HP:0000586) | 1.67808214 |
159 | Bicuspid aortic valve (HP:0001647) | 1.64555204 |
160 | Increased mean platelet volume (HP:0011877) | 1.64187125 |
161 | Congenital hip dislocation (HP:0001374) | 1.63139427 |
162 | Patellar aplasia (HP:0006443) | 1.62910060 |
163 | Broad thumb (HP:0011304) | 1.61960903 |
164 | Tongue fasciculations (HP:0001308) | 1.61918901 |
165 | Premature rupture of membranes (HP:0001788) | 1.61613845 |
166 | Aortic dissection (HP:0002647) | 1.61183860 |
167 | Lip pit (HP:0100267) | 1.60808209 |
168 | Recurrent bacterial skin infections (HP:0005406) | 1.59949730 |
169 | Vertebral fusion (HP:0002948) | 1.59609934 |
170 | Verrucae (HP:0200043) | 1.59508225 |
171 | Papilloma (HP:0012740) | 1.59508225 |
172 | Short 5th finger (HP:0009237) | 1.59499322 |
173 | Asymmetric septal hypertrophy (HP:0001670) | 1.59438029 |
174 | Increased density of long bones (HP:0006392) | 1.58952768 |
175 | Increased connective tissue (HP:0009025) | 1.58475660 |
176 | Myositis (HP:0100614) | 1.55982936 |
177 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.55434988 |
178 | Panhypogammaglobulinemia (HP:0003139) | 1.55167825 |
179 | Prolonged bleeding time (HP:0003010) | 1.55041987 |
180 | Deviation of the thumb (HP:0009603) | 1.54396414 |
181 | Increased IgE level (HP:0003212) | 1.54248664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.17130088 |
2 | TEC | 3.38043485 |
3 | ICK | 3.31691822 |
4 | CDK12 | 3.01392678 |
5 | MAP3K10 | 2.91764051 |
6 | EEF2K | 2.56992172 |
7 | MAP4K1 | 2.53825807 |
8 | DDR2 | 2.45925014 |
9 | TRIB3 | 2.37383984 |
10 | MAPK15 | 2.26542885 |
11 | STK16 | 2.17218224 |
12 | STK10 | 2.12267024 |
13 | ERN1 | 2.10326292 |
14 | MAP3K6 | 2.09309201 |
15 | TGFBR2 | 1.95258517 |
16 | SYK | 1.94341875 |
17 | CSK | 1.93221944 |
18 | MATK | 1.92278460 |
19 | PLK4 | 1.88794863 |
20 | MAP3K11 | 1.75784160 |
21 | BMX | 1.70955545 |
22 | TRPM7 | 1.70831439 |
23 | FES | 1.70035713 |
24 | PIM2 | 1.70020961 |
25 | PIM1 | 1.64681378 |
26 | CDK6 | 1.64119768 |
27 | TNK2 | 1.63853043 |
28 | EIF2AK3 | 1.63292710 |
29 | PDGFRA | 1.59529919 |
30 | TLK1 | 1.55307743 |
31 | KSR2 | 1.52856054 |
32 | TXK | 1.51527120 |
33 | PKN2 | 1.48109116 |
34 | IKBKE | 1.46786159 |
35 | CDK7 | 1.46379094 |
36 | NME1 | 1.45670973 |
37 | FGR | 1.43965601 |
38 | PRKD2 | 1.43115338 |
39 | TYRO3 | 1.39215700 |
40 | RPS6KB2 | 1.28164836 |
41 | IRAK3 | 1.26367080 |
42 | DYRK1B | 1.22132511 |
43 | RIPK1 | 1.21804775 |
44 | EPHB1 | 1.21628064 |
45 | TESK2 | 1.19912583 |
46 | NEK2 | 1.15882458 |
47 | GRK1 | 1.14773355 |
48 | TYK2 | 1.13753131 |
49 | PAK4 | 1.12767160 |
50 | CSF1R | 1.10616678 |
51 | LRRK2 | 1.10398647 |
52 | BMPR2 | 1.09595616 |
53 | IRAK4 | 1.09043596 |
54 | TTN | 1.08493786 |
55 | ZAP70 | 1.08309254 |
56 | MTOR | 1.08232635 |
57 | JAK3 | 1.06198556 |
58 | GRK6 | 1.05672593 |
59 | STK3 | 1.04697770 |
60 | PRPF4B | 1.03541850 |
61 | EIF2AK1 | 1.02232027 |
62 | CDK4 | 1.01868609 |
63 | MAP2K2 | 0.96721812 |
64 | PTK6 | 0.92082443 |
65 | CAMK1D | 0.92067206 |
66 | MAPKAPK3 | 0.91911686 |
67 | CHUK | 0.90607280 |
68 | ADRBK2 | 0.90355555 |
69 | EPHA2 | 0.90016068 |
70 | BLK | 0.89968470 |
71 | RPS6KC1 | 0.87918711 |
72 | RPS6KL1 | 0.87918711 |
73 | BTK | 0.87872338 |
74 | STK4 | 0.87442872 |
75 | RAF1 | 0.87129655 |
76 | MAPK11 | 0.86207143 |
77 | MAP2K3 | 0.85982910 |
78 | RPS6KA6 | 0.84821557 |
79 | DMPK | 0.84104167 |
80 | RPS6KA4 | 0.83987616 |
81 | SIK1 | 0.83095847 |
82 | YES1 | 0.82522501 |
83 | IKBKB | 0.81241578 |
84 | LATS1 | 0.77712739 |
85 | IRAK1 | 0.77648160 |
86 | HIPK2 | 0.77300108 |
87 | RPS6KA2 | 0.76677170 |
88 | TBK1 | 0.76160815 |
89 | MAP3K14 | 0.75472298 |
90 | SMG1 | 0.75342364 |
91 | MAPK7 | 0.71652942 |
92 | PDGFRB | 0.70689544 |
93 | MAP3K8 | 0.70625785 |
94 | CDC7 | 0.69601055 |
95 | LCK | 0.67814818 |
96 | GSK3A | 0.66907992 |
97 | NME2 | 0.66776264 |
98 | FLT3 | 0.66607188 |
99 | MAP3K2 | 0.66310407 |
100 | HCK | 0.66287290 |
101 | PAK2 | 0.65722498 |
102 | NUAK1 | 0.65600103 |
103 | TAOK1 | 0.65353529 |
104 | NEK9 | 0.65097323 |
105 | KIT | 0.64515351 |
106 | FGFR4 | 0.63916817 |
107 | KDR | 0.63891963 |
108 | ITK | 0.63316548 |
109 | PDK1 | 0.62983467 |
110 | MAPKAPK2 | 0.62510520 |
111 | MAP4K2 | 0.60885776 |
112 | FGFR3 | 0.59080239 |
113 | BCKDK | 0.58762508 |
114 | MAPKAPK5 | 0.58197115 |
115 | * MAPK3 | 0.58112396 |
116 | CLK1 | 0.57192947 |
117 | CDK9 | 0.57078404 |
118 | CHEK2 | 0.56826296 |
119 | RPS6KA1 | 0.56663545 |
120 | LYN | 0.56608734 |
121 | EGFR | 0.54863572 |
122 | GRK7 | 0.54577394 |
123 | MAP3K13 | 0.54408907 |
124 | MAP3K3 | 0.53152969 |
125 | ALK | 0.52008706 |
126 | JAK1 | 0.51977356 |
127 | ATR | 0.51849271 |
128 | TAOK3 | 0.50416997 |
129 | PTK2B | 0.50323364 |
130 | DYRK3 | 0.49105519 |
131 | MOS | 0.49013940 |
132 | MAP3K1 | 0.48709915 |
133 | JAK2 | 0.46657503 |
134 | RPS6KA5 | 0.46301475 |
135 | PIK3CG | 0.44225735 |
136 | BRD4 | 0.44202851 |
137 | PTK2 | 0.43450251 |
138 | AURKB | 0.43199504 |
139 | PRKCQ | 0.42608848 |
140 | TGFBR1 | 0.42590198 |
141 | MARK3 | 0.42171228 |
142 | MELK | 0.41778288 |
143 | CDC42BPA | 0.41481982 |
144 | CAMK1G | 0.40965573 |
145 | MAPK4 | 0.40159881 |
146 | TTK | 0.40006947 |
147 | DAPK1 | 0.38449339 |
148 | PDPK1 | 0.37787516 |
149 | * ABL1 | 0.36351463 |
150 | SIK3 | 0.32669174 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Asthma_Homo sapiens_hsa05310 | 3.91699748 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.42821621 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.28993613 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.19650302 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.59416985 |
6 | Base excision repair_Homo sapiens_hsa03410 | 2.30748289 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 2.29096110 |
8 | DNA replication_Homo sapiens_hsa03030 | 2.17198469 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.14398345 |
10 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.90774501 |
11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.82502196 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78098411 |
13 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.62355851 |
14 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.59835712 |
15 | * Adherens junction_Homo sapiens_hsa04520 | 1.55620977 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55198206 |
17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.53365412 |
18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52202339 |
19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50214450 |
20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50021390 |
21 | Cell cycle_Homo sapiens_hsa04110 | 1.44549477 |
22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43320513 |
23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42288966 |
24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41862253 |
25 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.39188934 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38498477 |
27 | RNA degradation_Homo sapiens_hsa03018 | 1.38376848 |
28 | Measles_Homo sapiens_hsa05162 | 1.38222654 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34764488 |
30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.33140537 |
31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28632622 |
32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28169835 |
33 | Spliceosome_Homo sapiens_hsa03040 | 1.23503718 |
34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21986076 |
35 | Hepatitis B_Homo sapiens_hsa05161 | 1.21361227 |
36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21127919 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21057503 |
38 | Legionellosis_Homo sapiens_hsa05134 | 1.20708485 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20453479 |
40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19718361 |
41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17942509 |
42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17095535 |
43 | * Shigellosis_Homo sapiens_hsa05131 | 1.17023963 |
44 | Lysine degradation_Homo sapiens_hsa00310 | 1.16305913 |
45 | Colorectal cancer_Homo sapiens_hsa05210 | 1.16300227 |
46 | RNA transport_Homo sapiens_hsa03013 | 1.15767888 |
47 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15433975 |
48 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.15287772 |
49 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15101904 |
50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14807900 |
51 | Apoptosis_Homo sapiens_hsa04210 | 1.13146394 |
52 | HTLV-I infection_Homo sapiens_hsa05166 | 1.13030252 |
53 | Bladder cancer_Homo sapiens_hsa05219 | 1.12503947 |
54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12298679 |
55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11998052 |
56 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10182841 |
57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09655912 |
58 | Focal adhesion_Homo sapiens_hsa04510 | 1.09139755 |
59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07801568 |
60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.07075099 |
61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04780258 |
62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04750347 |
63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03756685 |
64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99291897 |
65 | Hepatitis C_Homo sapiens_hsa05160 | 0.98345373 |
66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97872204 |
67 | Homologous recombination_Homo sapiens_hsa03440 | 0.94806273 |
68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94643603 |
69 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91135253 |
70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89839647 |
71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89783255 |
72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89607184 |
73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89316426 |
74 | Prostate cancer_Homo sapiens_hsa05215 | 0.89090689 |
75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.87774435 |
76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87632157 |
77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86411378 |
78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85741941 |
79 | Platelet activation_Homo sapiens_hsa04611 | 0.85555541 |
80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84387336 |
81 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83695033 |
82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83662348 |
83 | Pathways in cancer_Homo sapiens_hsa05200 | 0.82868873 |
84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80859680 |
85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.80820448 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79952037 |
87 | Influenza A_Homo sapiens_hsa05164 | 0.79464235 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79438508 |
89 | Malaria_Homo sapiens_hsa05144 | 0.79269315 |
90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79015237 |
91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77869859 |
92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77802045 |
93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77172109 |
94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76913525 |
95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76503146 |
96 | Tuberculosis_Homo sapiens_hsa05152 | 0.75547334 |
97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.74610514 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73240292 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73087689 |
100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71034190 |
101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70534004 |
102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70031309 |
103 | Amoebiasis_Homo sapiens_hsa05146 | 0.69567703 |
104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67963624 |
105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67677480 |
106 | Pertussis_Homo sapiens_hsa05133 | 0.67640447 |
107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67610762 |
108 | Lysosome_Homo sapiens_hsa04142 | 0.65832670 |
109 | Ribosome_Homo sapiens_hsa03010 | 0.64865230 |
110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64116516 |
111 | Insulin resistance_Homo sapiens_hsa04931 | 0.61012669 |
112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60443774 |
113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60320530 |
114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60258552 |
115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58686400 |
116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58423574 |
117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57515185 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57268901 |
119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56246361 |
120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55924893 |
121 | Endocytosis_Homo sapiens_hsa04144 | 0.54908578 |
122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54121675 |
123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.53418610 |
124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53174234 |
125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49210811 |
126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46837604 |
127 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40096289 |
128 | Phagosome_Homo sapiens_hsa04145 | 0.37258102 |
129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34489292 |
130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32350406 |
131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32242283 |
132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30229845 |
133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26861755 |
134 | Melanoma_Homo sapiens_hsa05218 | 0.25592750 |
135 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25446403 |
136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25371898 |
137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24272427 |